欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2017, Vol. 22 ›› Issue (4): 394-400.

• 基础研究 • 上一篇    下一篇

静脉注射黄芩苷、黄芩素在大鼠体内的药代规律比较研究

杨 迪1,袁婷婷2,干舒蕾1,崔亚娇1,丁 茹2,吴玉林1,杨 劲2   

  1. 1 中国药科大学基础医学与临床药学学院,2 药学院,南京 210009,江苏
  • 收稿日期:2016-12-29 修回日期:2017-03-02 出版日期:2017-04-26 发布日期:2017-04-26
  • 通讯作者: 吴玉林,男,博士,硕士生导师,主要从事心血管药理研究工作。 E-mail:wylcpu0801@163.com
  • 作者简介:杨迪,女,硕士,主要从事药代动力学研究工作。 E-mail:cpu-yangdi@163.com
  • 基金资助:

    国家科技重大专项项目(2013ZX09301303001007)

Comparative study on the pharmacokinetics of baicalin and baicalein in rats after intravenous administration

YANG Di 1, YUAN Tingting 2, GAN Shulei 1, CUI Yajiao 1 , DING Ru 2, WU Yulin 1,YANG Jing 2   

  1. 1 School of Basic Medicine and Clinical Pharmacy, 2 School of Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, China
  • Received:2016-12-29 Revised:2017-03-02 Online:2017-04-26 Published:2017-04-26

摘要:

目的: 比较研究静脉给药黄芩苷、黄芩素在大鼠体内药代规律。方法: 大鼠分别静脉注射等摩尔的黄芩苷、黄芩素,剂量为37 μmoL/kg,给药体积为10 mL/kg,于给药后0.08、0.17、0.33、0.5、1、2、4、6、8、10、12和24 h采集血样,用HPLC-MS/MS法同时测定血浆样本中黄芩苷和黄芩素浓度,血药浓度-时间数据及药代参数用BAPP软件进行药代动力学分析。结果: (1)大鼠血浆样本中能同时检测到黄芩苷和黄芩素。黄芩苷组中的原型药物黄芩苷的Cmax为(24.5±18.3) nmol/mL,AUC 0-24为(13.3±11.6)nmol·mL-1·h-1,黄芩素组中的原型药物黄芩素Cmax为(10.5±5.1) nmol/mL,AUC 0-24为(18.2±4.9) nmol·mL-1·h-1;(2)静脉注射黄芩苷后,代谢转化为黄芩素的转化率为26.5%;静脉注射黄芩素后,代谢转化为黄芩苷的转化率为35%。结论: 等摩尔给药情况下黄芩素的Cmax高于黄芩苷,AUC 0-24却相反,这可能是由于黄芩素亲脂性较高,分布较广,清除率较低导致的;提示静脉注射黄芩苷和黄芩素能在体内进行相互转化且黄芩素的转化率高于黄芩苷。

关键词: 黄芩苷, 黄芩素, 静脉注射, 药代动力学

Abstract:

AIM: To compare the pharmacokinetics of baicalin(BG)and baicalein (BL) in rats by intravenous administration. METHODS: Two groups of rats (5 per group) received an intravenous administration of BG or BL at equimolar dose of 37 μmol/kg and dosing volume of 10 mL/kg. After administration, blood samples were collected in 1.5 mL heparinized polythene tubes, at 0 (pre-dose), 0.08, 0.17, 0.33, 0.5, 1, 2, 4, 6, 8,12, 24 h after dosing, simultaneous determination of baicalin and baicalein in plasma by HPLC-MS / MS. RESULTS: BG and BL could be detected in all plasma after baicalein/baicalin was administrated intravenously to rats. In BG group, the C max of BG was (24.5±18.3)nmol/mL,AUC 0-24 was (13.3±11.6)nmol·mL-1·h-1 group. In BL group , the C max of BL was (10.5±5.1)nmol/mL,AUC 0-24 was (18.2±4.9)nmol·mL-1·h-1. The rate of BG transformed into BL was 26.5% in the BG group. The rate of BL transformed into BG was 35%. CONCLUSION: The Cmax of BL in BL group was significantly higher than that of BG in BG group after intravenous administration of equimolar dose of BG/BL; however, the AUC 0-24 value was opposite. It might be caused by the higher lipophilicity, the wider distribution; the lower clearance rate of baicalein. It is suggested that baicalin and baicalein can be transformed into each other in vivo. The rate of BL transforming into BG is significantly higher than that of BG transforming into BL.

Key words: baicalein, baicalin, intravenous administration, pharmacokinetic

中图分类号: